AtriCure (ATRC) Tops Q3 EPS by 7c
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $22.61 -1.91%
Revenue Growth %: +14.3%
Financial Fact:
Basic and diluted net loss per share: -0.21
Today's EPS Names:
FRSB, DGICA, UXIN, More
Revenue Growth %: +14.3%
Financial Fact:
Basic and diluted net loss per share: -0.21
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q3 EPS of ($0.21), $0.07 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $38.2 million versus the consensus estimate of $37.85 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Byline Bancorp (BY) Tops Q1 EPS by 6c
- Tenaris SA (TS) Tops Q1 EPS by 22c; offers outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
